According to our new market research study on "Terahertz Technology Market to 2028 – Global Analysis and Forecast – by Type and Application," the market is expected to grow from US$ 135.29 million in 2022 to US$ 349.00 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2022 to 2028. The report highlights trends prevailing in the market, and drivers and restraints pertaining to the global medical terahertz technology market growth.

Terahertz refers to the electromagnetic waves with the frequency range between millimeter-wave and infrared, approximately from 300 GHz up to 10 THz. Intermolecular bonds, such as the hydrogen bonds in water and the N-H bonds in proteins, strongly absorb THz radiation. This means that it is extremely sensitive to little changes, such as an increase in blood flow or water content, which may indicate the presence of disease. Terahertz technology is a fast-growing field with applications in biology and medicine, medical imaging, material spectroscopy and sensing, security, monitoring, and spectroscopy in the pharmaceutical business.

Get Sample Copy @ https://www.theinsightpartners.com/sample/TIPTE100001364/ 

According to WHO, in many regions, cancer is the second-largest cause of death. Digestive malignancies account for a significant fraction of all tumors, and their occurrence is predicted to rise faster than other tumor types due to bad lifestyle habits. The information obtained by THz-based scanning can prove beneficial in the care of cancer patients and, more crucially, in the early diagnosis of various solid tumors, because it can correctly differentiate between different types of molecules based on water content. According to GLOBOCAN, 19.3 million new cancer cases were reported in 2020, with ~10.0 million cancer deaths. In 2018, ~4.8 million new instances of gastrointestinal (GI) malignancies were diagnosed worldwide, with 3.4 million deaths. GI malignancies are responsible for 26% of global cancer incidence and 35% of cancer-related deaths. Recent advancements in medical imaging can substantially lead to improvements in the early detection and treatment of various clinical disorders. THz imaging devices can also aid in detecting early cancer before it becomes apparent or detectable by other means.

The medical terahertz technology market in the US is expected to grow from US$ 43.42 million in 2022 to US$ 114.24 million by 2028, reporting a CAGR of 17.5% during 2022–2028. As per the Centers for Disease Control and Prevention (CDC), in the US, 1,752,735 new cancer cases were diagnosed in 2019, and 599,589 patients died due to cancer. The increasing prevalence of cancer is a key factor contributing to the medical terahertz technology market in the US. Terahertz technology is also used for diagnosing dental disorders. As per the CDC, in 2019, 13.2% of children aged 5-19 years and 25.9% of adults aged 20–44 in the US had untreated dental caries. The presence of major medical terahertz system providers is likely to favor market growth in the US. For instance, Terasense Group Inc. is a leading manufacturer of innovative portable terahertz imaging systems and cameras, terahertz sources, and terahertz detectors. It offers a product portfolio based on cutting-edge technologies.

Browse Complete Report @ https://www.theinsightpartners.com/reports/terahertz-technology-industry 

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com